NASDAQ: MXCT
Maxcyte Inc Stock Ownership - Who owns Maxcyte?

Insider buying vs selling

Have Maxcyte Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Douglas J. SwirskyCHIEF FINANCIAL OFFICER2025-03-186,939$3.18
$22.06kSell
Ali SoleymannezhadChief Commercial Officer2025-03-181,211$3.18
$3.85kSell
David I. SandovalGENERAL COUNSEL2025-03-18353$3.18
$1.12kSell
John Joseph JohnstonDirector2025-01-273,000$2.93
$8.80kBuy
John Joseph JohnstonDirector2025-01-273,000$4.65
$13.93kSell
David I. SandovalGENERAL COUNSEL2025-01-134,466$4.54
$20.27kSell
John Joseph JohnstonDirector2024-12-263,000$4.01
$12.02kSell
John Joseph JohnstonDirector2024-12-263,000$2.93
$8.80kBuy
John Joseph JohnstonDirector2024-12-09891$2.93
$2.61kBuy
John Joseph JohnstonDirector2024-12-091,121$1.64
$1.84kBuy

1 of 4

MXCT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MXCT insiders and whales buy or sell their stock.

MXCT Shareholders

What type of owners hold Maxcyte Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cadian Capital Management LP9.43%10,027,727$22.06MInstitution
Casdin Partners Master Fund LP9.41%10,000,000$22.00MInsider
Blackrock Inc7.68%8,168,376$17.97MInstitution
Morgan Stanley6.58%7,000,799$15.40MInstitution
Vanguard Group Inc5.23%5,565,665$12.24MInstitution
Vitruvian Partners LLP4.74%5,043,356$11.10MInstitution
Mirabella Financial Services LLP3.48%3,700,000$8.14MInstitution
Mudita Advisors LLP3.13%3,328,441$7.32MInstitution
Fmr LLC2.77%2,944,970$6.48MInstitution
Geode Capital Management LLC2.43%2,581,005$5.68MInstitution

1 of 3

MXCT vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MXCT67.98%11.55%Net Selling
TCMD76.79%23.21%Net SellingNet Selling
MASS49.06%50.94%Net BuyingNet Buying
SGHT31.66%58.56%Net BuyingNet Buying
BWAY15.91%0.00%

Maxcyte Stock Ownership FAQ

Who owns Maxcyte?

Maxcyte (NASDAQ: MXCT) is owned by 67.98% institutional shareholders, 11.55% Maxcyte insiders, and 20.47% retail investors. Casdin Partners Master Fund LP is the largest individual Maxcyte shareholder, owning 10.00M shares representing 9.41% of the company. Casdin Partners Master Fund LP's Maxcyte shares are currently valued at $22.00M.

If you're new to stock investing, here's how to buy Maxcyte stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.